Market Insights Health Plan Best Practices: Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)

This educational activity is not accredited for continuing pharmacy education credit.

Market Insights programs form an integral component of AMCP's efforts to identify deeper insights to guide coverage, access, and clinical management decisions. This non-promotional, sponsored webinar will review health plan best practice recommendations for Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC) with an expert panel of oncology and managed care experts.

Given the central role of managed care and payer professionals in enhancing the value and accessibility of cancer care, comprehending the best practices for biomarker testing in NSCLC is paramount. These best practices have been developed through expert interviews, a nationwide survey, and multistakeholder workshop, and are founded on the discoveries from the Market Insights program focused on Bridging the Gaps in Precision Oncology: Opportunities in NSCLC.

During this webinar, our panel of experts will delve into health plan best practices concerning biomarker testing in NSCLC, present the results of a national survey among managed care oncology professionals, and explore the elements of high-quality care that can advance health equity and address unmet needs in NSCLC. Following the presentation, there will be an opportunity to engage with the panelists during a live Q&A session.

Learn About:

At the completion of this activity, participants should be able to:

• Explore health plan practices for biomarker testing in NSCLC
• Discuss key insights from a national managed care oncology survey on biomarker testing in NSCLC
• Examine strategies available to managed care professionals to address known gaps in biomarker testing
• Identify components of high-quality care that improve health equity and address unmet needs in cancer care

Expert Faculty:

Ryan Haumschild, PharmD, MS, MBA (Moderator)
Director of Pharmacy Services, Emory Healthcare and Winsor Cancer Institute

Wendy Bailey, RPh, BSPharm, MSPharm, MBA
Principal
Bailey Healthcare Consulting

Laura Bobolts, PharmD, BCOP
SVP, Clinical Strategy and Growth, OncoHealth

Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Assistant Vice President – System Oncology Pharmacy, Baptist Health South Florida

Tim Mok, PharmD, BCPS, BCOP
Hematology Oncology Pharmacy Research Analyst, Kaiser Permanente

Susan Wescott, R.Ph, MBA
Senior Director of Pharmacy
Managed Care Mayo Clinic

Target Audience

The primary target audience for this initiative consists of medical directors, pharmacy directors, clinical pharmacists, specialty pharmacists, registered nurses, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee for this educational activity.